
Activities
Work package 4: Phase Ia/b clinical trial in The Netherlands and Burkina Faso
Led by Leiden University Medical Center, The Netherlands
The main objectives of this work package are to:
-
To evaluate the safety of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.
-
To assess the immunogenicity of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.
Partner